Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial.

Jin J ZhouDawn C SchwenkeGideon BahnPeter Reavennull null

Published in: Diabetes care (2018)

Our analysis indicates that in the VADT, variability of fasting glucose plays a role in the development of CVD complications beyond the influence of standard fasting glucose measures. The adverse consequences of fasting glucose variability on CVD appear greatest in those receiving intensive glucose control.

Keyphrases

blood glucose
glycemic control
type diabetes
insulin resistance
blood pressure
clinical trial
cardiovascular disease
randomized controlled trial
risk factors
skeletal muscle
data analysis
open label